Literature DB >> 30756071

Intra-Vesical Colistin for Pseudomonas aeruginosa Urinary Tract Infections.

Rui Encarnado Assis1, Inês Coelho1, André Real1, Luís França1, Ana Araújo1, Tiago Pereira1, Nuno Catorze1.   

Abstract

The numbers of multiple drug-resistant Gram-negative bacterial infections are rising worldwide. The threat is increased by the lack of new antibiotics, so clinicians are turning to older drugs previously abandoned due to their recognized toxicity, such as colistin. However, the need to avoid kidney toxicity from colistin has led to its topical use. We present the case of a patient with type I cardiorenal syndrome with cystitis due to multiple drug-resistant Pseudomonas aeruginosa who was successfully treated with intravesical instillation of colistin. LEARNING POINTS: The case report is one of the few in the literature on the intravesical instillation of colistin to address lower urinary tract infection.Isolated intravesical colistin instillation was effective in a patient with anuria.

Entities:  

Keywords:  Colistin; Pseudomonas; multiple drug resistance

Year:  2019        PMID: 30756071      PMCID: PMC6372045          DOI: 10.12890/2019_000996

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  7 in total

1.  [Intravesical instillations of colistin in urine infections with multiresistant pathogens].

Authors:  B Garcés-Jimeno; T M Tomasa-Irriguible; J A Moreno-Molina
Journal:  Med Intensiva       Date:  2014-09-30       Impact factor: 2.491

Review 2.  Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature.

Authors:  R Giua; C Pedone; L Cortese; R Antonelli Incalzi
Journal:  Infection       Date:  2013-07-25       Impact factor: 3.553

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Colistin.

Authors:  Nicolas Grégoire; Vincent Aranzana-Climent; Sophie Magréault; Sandrine Marchand; William Couet
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

4.  Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Catia Cillóniz; Albert Gabarrús; Miquel Ferrer; Jorge Puig de la Bellacasa; Mariano Rinaudo; Josep Mensa; Michael S Niederman; Antoni Torres
Journal:  Chest       Date:  2016-04-07       Impact factor: 9.410

5.  Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.

Authors:  Marin H Kollef; Jean Chastre; Jean-Yves Fagon; Bruno François; Michael S Niederman; Jordi Rello; Antoni Torres; Jean-Louis Vincent; Richard G Wunderink; Kerry W Go; Christine Rehm
Journal:  Crit Care Med       Date:  2014-10       Impact factor: 7.598

Review 6.  Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.

Authors:  P Ruiz-Garbajosa; R Cantón
Journal:  Rev Esp Quimioter       Date:  2017-09       Impact factor: 1.553

Review 7.  Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review.

Authors:  Amelia Pietropaolo; Patrick Jones; Mike Moors; Brian Birch; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2018-08-09       Impact factor: 3.092

  7 in total
  1 in total

Review 1.  Management of urinary tract infection in women: A practical approach for everyday practice.

Authors:  Nassib F Abou Heidar; Jad A Degheili; Aline A Yacoubian; Raja B Khauli
Journal:  Urol Ann       Date:  2019 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.